PotNetwork Holding, Inc. announced record breaking sales performance for March 2018. With over $2.2 million in sales revenue recorded across the month, the company has posted a 152% year over year increase when compared with March 2017.
With over $6.3 million in revenues recorded for Q1 of 2018, PotNetwork Holding, Inc. is well on track to exceed its performance in 2017. The company recently announced the release of audited consolidated financial statements reporting 2017 sales of $14.5 million, with gross profits of $5,180,865, and, despite making large reinvestments in its future growth, positive net income of $178,918.
The company's wholly owned subsidiary, Diamond CBD, Inc. has been aggressively exploring new business development opportunities. In March 2018, the company presented its products at the high profile industry leading trade shows ASD Market Week and Global Pet Expo.
As a provider of the highest quality CBD hemp oil products, Diamond CBD, Inc. continues to attract new customers in verticals such as petcare products which are allowing the brand to differentiate itself in the market.
In 2017, American pet owners spent more than $69.36 billion on their pets. Of that number, nearly $15 million was spent on over-the-counter health and wellness products in the same category as Diamond CBD, Inc.'s recently released "MediPets" product line.
Between April 17 and 27, 2018, Diamond CBD, Inc. is launching an African business development project by contributing material support and resources towards community action projects taking place across Kenya.
Diamond CBD, Inc.'s efforts in Kenya align the brand's corporate culture with values of corporate social responsibility and service to the community.
Recently, the Company launched its first international charity event in Manila, Philippines. Co-sponsored by Diamond CBD, Inc.'s marketing partner, XPO2, this charitable event offered over 100 at-risk children and adolescents hundreds of items of food as well as critical supplies such as soap, clothing and blankets.
Diamond CBD, Inc. is dedicated to offering financial returns to investors as well as measurable benefits to society and the local environment in which the business operates.
About Diamond CBD, Inc.: Diamond CBD focuses on the research, development, and multinational marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD's team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.
About PotNetwork Holding, Inc: PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiary, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.
Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.